Intron Life Sciences Private Limited, a active private limited company, was established on 28 September 2018 in Gundlapalli, Andhra Pradesh, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24299AP2018PTC109365. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹22.80 Cr and a paid-up capital of ₹20.32 Cr.
It upholds a compliant status. Employing 160 professional, Its leadership includes Nithyagovind (Director), Sreemannarayana Murali Krishna Pasumarthi (Managing Director), Pavan Kumar Velpuri (Whole-Time Director). Past directors included Honey Lahoti, Pavan Kumar Velpuri, Sreedhar Reddy Arugunta. It holds ₹24.00 Cr open charges and ₹22.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.368 & 375 Apiic Industrial Growth Centre,, Gundlapalli, Andhra Pradesh, 523211.
U24299AP2018PTC109365
109365
28 September 2018
₹22.80 Cr
₹20.32 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Intron Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nithyagovind | Director | 04 Dec 2018 | Current |
| Sreemannarayana Murali Krishna Pasumarthi | Managing Director | 28 Sep 2018 | Current |
| Pavan Kumar Velpuri | Whole-Time Director | 28 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Apr 2021 | Past |
| Pramod Abcsdd | Director | 26 Feb 2024 | Past |
| Pramod Abcsdd | Director | 19 Apr 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Intron Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25% increase. The company also saw a substantial fall in profitability, with a 10.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Intron Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹240,038,555.00
₹220,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2024 | Hdfc Bank Limited | ₹2.02 M | Open |
| 15 Nov 2023 | Hdfc Bank Limited | ₹2.09 M | Open |
| 09 Feb 2023 | Hdfc Bank Limited | ₹6.10 M | Open |
| 13 Jan 2023 | Axis Bank Limited | ₹22.30 Cr | Open |
| 25 Apr 2022 | Hdfc Bank Limited | ₹6.83 M | Open |
Explore comprehensive loan charge details -
Intron Life Sciences has a workforce of 160 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Intron Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intron Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 101041924 was registered on 11 Nov 2024. was completed.
Progress on Intron Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Axis Bank Limited of Rs. 22.30 Cr registered on 13 Jan 2023 with Charge ID 100681962 was modified on 09 Aug 2024. was documented.
Intron Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 100816777 was registered on 15 Nov 2023. was completed.
The activity A charge registered on 24 Dec 2021 via Charge ID 100513886 with Others was fully satisfied on 01 Mar 2023. was completed.
When you invest in Indian healthcare and pharmaceuticals, you're making bank 💰 InvAscent raised $250 million for their third fund and have a great track record. They invest in quality medicines and healthcare, and have already made successful exits. The sector is performing well and attracting more investors. In 2018, $8.1 billion was raised by PE/VC funds in India, the highest ever. India is becoming a hot spot for investments, so don't miss out! 🔥🇮🇳.
The CIN of Intron Life Sciences Private Limited is U24299AP2018PTC109365.
Intron Life Sciences Private Limited is headquartered at Plot No.368 & 375 Apiic Industrial Growth Centre,, Gundlapalli, Andhra Pradesh, 523211.
Intron Life Sciences Private Limited was incorporated on 28 September 2018.
The current directors of Intron Life Sciences Private Limited are
The primary industry of Intron Life Sciences Private Limited is Manufacturing.
Intron Life Sciences Private Limited is unlisted.
The authorized capital of Intron Life Sciences Private Limited is ₹22.80 Cr, and the paid-up capital is ₹20.32 Cr.
The compliance status of Intron Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX